{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for estramustine root_references_citation in Reference Text / Citation (approximate match)
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
US Previously Marketed
Source:
CALCIBIND by MISSION PHARMA
(1982)
Source URL:
First approved in 1982
Source:
CALCIBIND by MISSION PHARMA
Source URL:
Class:
POLYMER
Status:
US Previously Marketed
Source:
ESTRADURIN by WYETH AYERST
(1957)
Source URL:
First approved in 1957
Source:
ESTRADURIN by WYETH AYERST
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 358A
(2018)
Source URL:
First approved in 2018
Source:
21 CFR 358A
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 358H
(2018)
Source URL:
First approved in 2018
Source:
21 CFR 358H
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDM SCALP by Damomedical Ltd.
(2014)
Source URL:
First approved in 2014
Source:
NDM SCALP by Damomedical Ltd.
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2014)
Source URL:
First approved in 2014
Source:
21 CFR 347
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ACNE WIPEOUT TIME-RELEASED RETINOL PLUS NIGHT CREAM by University Medical Pharmaceuticals Corp.
(2020)
Source URL:
First approved in 2013
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2021)
Source URL:
First approved in 2013
Source:
21 CFR 352
Source URL:
Class:
POLYMER
